Solution conformation of an immunogenic peptide from HRV2: Comparison with the conformation found in a complex with a Fab fragment of an anti-HRV2 neutralizing antibody

Journal of Peptide Science

Volumn 4, Issue 2, 1998, Pages 101-110

  Molins, M Antònia ^a   Contreras, Miquel Àngel ^a   Fita, Ignacio ^b   Pons, Miquel ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CSIC   (Spain)

Author keywords

NMR; Random coil; Rhinovirus; Synthetic vaccine

Indexed keywords

RHINOVIRUS;

ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; PEPTIDE FRAGMENT; VACCINE; VIRUS ANTIGEN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; RHINOVIRUS;

AMINO ACID SEQUENCE; ANTIBODIES; ANTIGENS, VIRAL; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOGLOBULIN FAB FRAGMENTS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; RHINOVIRUS; VACCINES; VIRAL PROTEINS;

EID: 0032039412     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1387(199804)4:2<101::AID-PSC133>3.0.CO;2-C     Document Type: Article

References (30)

1. G. M. Muller, M. Shapira and R. Arnon (1982). Anti-influenza response achieved by immunization with a synthetic conjugate. Proc. Natl Acad. Sci. USA 79, 569-573.
2. M. J. Francis, G. Z. Hastings, D. V. Sangar, R. P. Clark, A. Syred, B. E. Clarke, D. J. Rowlands and F. Brown (1987). A synthetic peptide which elicits neutralizing antibody against human rhinovirus type 2. J. Gen. Virol. 68, 2687-2691.
3. N. R. Parry, P. V. Barnet, E. J. Ouldridge, D. J. Rowlands and E. Brown (1989). Neutralizing epitopes of type O foot-and-mouth disease virus II. Mapping three conformational sites with synthetic peptide reagents. J. Gen. Virol. 70, 1493-1503.
4. K. Javaherian, A. J. Langlois, G. J. LaRosa, A. T. Profy, D. P. Bolognesi, W. C. Herlihy, S. D. Putney and T. J. Mathews (1990). Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1. Science 250, 1590-1593.
5. J. M. Rini, R L. Stanfield, E. A. Stura, P. A. Salinas, A. T. Profy and I. A. Wilson (1993). Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with his V3 loop peptide antigen. Proc. Natl Acad. Sci. USA 90, 6325-6329.
6. F. Audibert, M. Jolivet, L. Chedid, R. Arnon and M. Sela (1982). Successful immunization with a totally synthetic diphtheria vaccine. Proc. Natl Acad. Sci. USA 79, 5042-5046.
7. M. E. Patarroyo, R. Amador, P. Clavijo, A. Moreno, F. Guzman, P. Romero, R. Tascon, A. Franco, L. A. Murillo, G. Ponton and G. Trujillo (1988). A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature 332, 158-161.
8. M. G. Rossman and J. E. Johnson (1989). Icosahedral RNA virus structure. Annu. Rev. Biochem. 58, 533-573.
9. G. Appleyard, S. M. Russell, B. E. Clarke, S. A. Speller, M. Trowbridge and J. Vadolas (1990). Neutralization epitopes of human rhinovirus type 2. J. Gen. Virol. 71, 1275-1282.
10. S. Kim, T. J. Smith, M. S. Chapman, M. G. Rossmann, D. C. Pevear, F. J. Dutko, P. J. Felock, G. D. Diana and M. A. McKinlay (1989). Crystal structure of human rhinovirus serotype 1A (HRV1A). J. Mol. Biol. 210, 91-111.
11. J. Tormo, D. Blaas, N. R. Parry, D. Rowlands, D. Stuart and I. Fita (1994). Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2. EMBO J. 13, 2247-2256.
12. G. Z. Hastings, S. A. Speller and M. J. Francis (1990). Neutralizing antibodies to human rhinovirus produced in laboratory animals and humans that recognize a linear structure from VP2. J. Gen. Virol. 71, 3055-3059.
13. L. J. Smith, K. M. Fiebig, H. Schwalbe and C. M. Dobson (1996). The concept of a random coil. Residual structure in peptides and denatured proteins. Folding Design 1, R95-R106.
14. E. Jabri, M. H. Lee, P. A. Hausinger and P. A. Karplus (1992). Preliminary crystallographic studies of urease from jack bean and from Klebsiella aerogenes. J. Mol. Biol. 227, 934-937.
15. 13C NMR assignment and characterization of residual structure. J. Mol. Biol. 259, 805-816.
16. 1H-NMR studies on the conformational properties of peptide fragments from the C-terminal domain of thermolysin. Eur. J. Biochem. 211, 569-581.
17. J. Saulitis and E. Liepins (1990). Quantitative evaluation of interproton distances in peptides by two-dimensional Overhauser effect spectroscopy. J. Magn. Reson. 87, 80-91.
18. 2O at low temperature. J. Mol. Struct. 143, 435-438.
19. 476, contained in the extended carboxyl cytoplasmic tail, are critical for targeting of the resident lysosomal membrane protein LIMP II to lysosomes. J. Biol. Chem. 269, 6622-6631.
20. 1H-NMR titration shifts for studies of polypeptide conformation. Biopolymers 18, 299-311.
21. M. Delepierre, C. M. Dobson, M. Karplus, F. M. Poulsen, D. J. States and R. E. Wedin (1987). Electrostatic effects and hydrogen exchange behaviour in proteins. The pH dependence of exchange rates in lysozyme. J. Mol. Biol. 197, 111-130.
22. R. L. Stanfield, T. M. Fieser, R. A. Lerner and I. A. Wilson (1990). Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 Å. Science 248, 712-719.
23. J. B. Ghiara, E. A. Stura, R. L. Stanfield, A. T. Profy and I. A. Wilson (1994). Crystal structure of the principal neutralization site of HIV-1. Science 264, 82-85.
24. A. P. Campbell, C. McInnes, R. S. Hodges and B. D. Sykes (1995). Comparison of NMR solution structures of the receptor binding domains of Pseudomonos aeruginosa pili strains PAO, KB7 and PAK: Implications for receptor binding and synthetic vaccine design. Biochemistry 34, 16255-16268.
25. H. J. Dyson, K. J. Cross, R. A. Houghten, I. A. Wilson, P. E. Wright and R. A. Lerner (1985). The immunodominant site of a synthetic immunogen has a conformational preference in water for a type-II reverse turn. Nature 318, 480-183.
26. M. Blumenstein, G. R. Matsueda, S. Timmons and J. Hawiger (1992). A β-turn is present in the 392-411 segment of the human fibrinogen γ-chain. Effects of structural changes in this segment on affinity to antibody 4A5. Biochemistry 31, 10692-10698.
27. A. P. Campbell, B. D. Sykes, E. Norrby, N. Assa-Munt and H. J. Dyson (1996). Solution conformation of an immunogenic peptide derived from the principal neutralizing determinant of the HIV-2 envelope glycoprotein gp125. Folding Design 1, 157-165.
28. D. Logan, R. Abu-Ghazaleh, W. Blakemore, S. Curry, T. Jackson, A. King, S. Lea, R. Lewis, J. Newman, N. Parry, D. Rowlands, D. Stuart and E. Fry (1993). Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 362, 566-568.
29. N. Verdaguer, M. G. Mateu, D. Andreu, E. Giralt, E. Domingo and I. Fita (1995). Structure of the major antigenic loop of foot-and-mouth disease virus complexed with a neutralizing antibody: Direct involvement of the Arg-Gly-Asp motif in the interaction. EMBO J. 14, 1690-1696.
30. M. G. Mateu, M. L. Valero, D. Andreu and E. Domingo (1996). Systematic replacement of amino acid residues within an Arg-Gly-Asp containing loop of foot-and-mouth disease virus and effect on cell recognition. J. Biol. Chem. 271, 12814-12819.